Welcome to our dedicated page for TRUPANION SEC filings (Ticker: TRUP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on TRUPANION's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into TRUPANION's regulatory disclosures and financial reporting.
Trupanion, Inc. (TRUP) Chief Financial Officer Fawwad Qureshi reported transactions on 08/22/2025 related to vested restricted stock units (RSUs). The filing shows RSUs converted into common stock on a one-for-one basis and portions of the vested shares were withheld by the issuer to satisfy income tax withholding obligations. The Form 4 discloses withheld share counts and a per-share withholding price of $46.63 for the withheld shares. The filing also lists the underlying RSU grants that gave rise to the vesting: 7,304 RSUs, 5,000 RSUs, and 41,980 RSUs (grants dated February 27, 2024 and February 27, 2025) with scheduled vesting schedules described in the explanation. The report is signed by an attorney-in-fact on behalf of Mr. Qureshi and dated 08/26/2025.
Form 144 notice for Trupanion, Inc. (TRUP) reports a proposed sale of 2,800 shares of Common stock through Morgan Stanley Smith Barney LLC on 08/26/2025 with an aggregate market value of $127,573.88. The filing lists total shares outstanding as 42,994,675. The securities were acquired as restricted stock from the issuer on 08/25/2025 (1,971 shares) and 08/22/2025 (829 shares), with payment dates matching acquisition dates and marked as Not Applicable for non-cash consideration. The filing also discloses prior sales by the same person: 2,534 shares sold on 05/29/2025 for $122,405.63 and 828 shares sold on 05/27/2025 for $37,698.84. The notice includes the standard signature representation that the seller is not aware of undisclosed material adverse information.
Emily Dreyer, Chief Revenue Officer of Trupanion, Inc. (TRUP), was granted 10,108 restricted stock units (RSUs) on 08/15/2025. Each RSU converts one-for-one into common stock and the reported post-transaction beneficial ownership is 10,108 shares held directly. The RSUs vest as to one-quarter of the total on 08/25/2026 and thereafter 1/16th of the total each quarter, subject to continued service. The grant was reported on Form 4 and signed by an attorney-in-fact on 08/19/2025.
Wellington Management entities filed a Schedule 13G/A reporting beneficial ownership of Trupanion, Inc. common stock. They report beneficial ownership of 2,038,458 shares, representing 4.76% of the outstanding class. The filing shows shared voting power of 1,604,789 shares and shared dispositive power of 2,038,365 shares, with no sole voting or dispositive power reported.
The securities are owned of record by clients of the Wellington Investment Advisers and are held in the ordinary course of business; the filing states the holdings were not acquired to change or influence control. Reporting persons are identified as holding companies (HC) and the listed Wellington advisers are classified as investment advisers (IA).
Trupanion’s Q2-25 10-Q shows a return to profitability and improved operating leverage. Revenue grew 12.3% YoY to $353.6 m, driven mainly by a 16% increase in subscription revenue to $242.2 m, while other-business revenue rose 4.9% to $111.4 m.
Margins strengthened. Cost of revenue rose 8.8%, lifting gross margin to 15.5% (vs 12.8%). Operating expenses increased 14.9% to $52.5 m, but operating income swung to $2.3 m from a $5.5 m loss. Net income reached $9.4 m (-$5.9 m LY), or $0.22 diluted EPS, aided by an $7.8 m gain on a non-monetary exchange of Baystride preferred stock for IP.
Cash & balance sheet. Operating cash flow improved to $31.0 m (vs $9.3 m), though total cash, equivalents and restricted cash fell $35.1 m to $164.5 m after $14.9 m voluntary term-loan repayment and $142 m securities purchases. Long-term debt declined to $113.1 m.
Key operating metrics.
- Total pets enrolled: 1.66 m (-2.3% YoY); subscription pets: 1.07 m (+4.4%).
- Monthly ARPP: $79.93 (+11.5%).
- Average PAC: $276 (+19.5%).
- Average monthly retention: 98.29% (-5 bp).
Guidance not provided in the filing.